FDA Logo--links to FDA home page
U.S. Food and Drug Administration
HHS Log--links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA


horizontal rule

John Robert Dyer

John Robert Dyer is the Deputy Commissioner for Operations and Chief Operating Officer (COO) of the Food and Drug Administration (FDA), a Federal agency within the United States Department of Health and Human Services (DHHS). Mr. Dyer is the designate of the FDA Commissioner for the overall day-to-day operations of the agency to assure the timely and effective implementation of operations and high quality delivery of services across the agency. He concentrates on strengthening FDA-wide management, infrastructure, business processes, information technology (IT), and implementation and coordination of food and medical product import and safety protection plans and initiatives across FDA. Mr. Dyer interacts with the Commissioner, Deputy Commissioners and the Center Directors on a daily basis and chairs the FDA Management Council, a governing board that makes decisions impacting the overall agency operations.

As the COO, Mr. Dyer has been instrumental in the successful development of the first-ever Food Protection Plan (FPP) and the implementation of the Import Safety Action Plan (ISAP) initiatives. He has also been involved in assuring the timely and effective implementation of the recently enacted Food and Drug Administration Amendment Act of 2007 (FDAAA). This has involved the expansion of user fee funding, expansion and integration of new data management systems, large scale hiring of new medical specialties, and the changing and issuance of many guidance’s and regulations.

He leads the consolidation of FDA science and business operations at the new $1.1 billion FDA campus at White Oak in Silver Spring, Maryland. Under his direction, more than 2,500 employees were physically located on the campus as of June 2008 and by spring 2010 close to 4,500 employees will be on campus.

Prior to joining FDA, Mr. Dyer served as the COO, at the Centers for Medicare and Medicaid (CMS) within DHHS from 2004–2006. He led the implementation of the Medicare Modernization Act (MMA) which provided a new Medicare prescription drug benefit for the first time with more choices in health care coverage and better health care benefits for the 43 million eligible Medicare beneficiaries.

Prior to joining CMS, Mr. Dyer worked for 4 years in the private sector as a private consultant for information technology and executive leadership development firms and as an entrepreneur in several industries in Guatemala, his mother’s family homeland. He was Senior Vice President of SAIC, a Fortune 500 employee-owned research and engineering firm where he was the lead on business development in the Federal health sector.

Mr. Dyer previously held executive positions with the Social Security Administration (SSA) as the Principal Deputy Commissioner (1995-2000) responsible for the overall day-to-day operations of the Agency, and prior to that as the Deputy Commissioner for Finance, Assessment and Management. Mr. Dyer was the Chief Financial Officer from 1988 to 1995. From 1982-1988, Mr. Dyer was the Director for Budget and Management at CMS (then HCFA).

horizontal rule